KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Assets (2016 - 2025)

Resmed's Assets history spans 16 years, with the latest figure at $8.5 billion for Q4 2025.

  • For Q4 2025, Assets rose 19.07% year-over-year to $8.5 billion; the TTM value through Dec 2025 reached $8.5 billion, up 19.07%, while the annual FY2025 figure was $8.2 billion, 18.95% up from the prior year.
  • Assets reached $8.5 billion in Q4 2025 per RMD's latest filing, up from $8.3 billion in the prior quarter.
  • In the past five years, Assets ranged from a high of $8.5 billion in Q4 2025 to a low of $4.6 billion in Q1 2021.
  • Average Assets over 5 years is $6.4 billion, with a median of $6.7 billion recorded in 2023.
  • Peak YoY movement for Assets: skyrocketed 41.0% in 2022, then increased 1.5% in 2024.
  • A 5-year view of Assets shows it stood at $4.7 billion in 2021, then skyrocketed by 41.0% to $6.7 billion in 2022, then rose by 3.43% to $6.9 billion in 2023, then rose by 3.42% to $7.1 billion in 2024, then increased by 19.07% to $8.5 billion in 2025.
  • Per Business Quant, the three most recent readings for RMD's Assets are $8.5 billion (Q4 2025), $8.3 billion (Q3 2025), and $8.2 billion (Q2 2025).